Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. (Q53048468)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. |
scientific article |
Statements
Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. (English)
1 reference
W C Lee
1 reference
C Conner
1 reference
M Hammer
1 reference
25 February 2011
1 reference
27
1 reference
5
1 reference
897-906
1 reference
Identifiers
1 reference